24/7 Patient Assistance: 760-405-8205

Carolyn Mulroney, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Carolyn Mulroney graduated from the Johns Hopkins University. She completed both her internship and residency program at the Duke University. Then, she attended two fellowship training programs. She is specialized in Medical Oncology and board certified in Hematology. Dr. Mulroney has been in practice for more than 20 years and is affiliated with the UC San Diego Health System. During her career, she has also contributed to 3 clinical research publications.



  • Education & Training

    dept_icon

    Johns Hopkins University / School Of Medicine Graduated in 1986

    Medical School

    dept_icon

    Duke University Completed in 1987

    Internship

    dept_icon

    Duke Medical Center Completed in 1989

    Residency

    dept_icon

    University Of California At San Francisco Completed in 1992

    Fellowship

    dept_icon

    University Of Washington Medical Center Completed in 1990

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Hematology

  • Hospital & Practice

    UC San Diego Health System

    Languages: English/Spanish

    (858) 657-7000

    200 West Arbor Drive

    San Diego, California 92103

    Read More
  • Publications & Memberships

    Dr. Carolyn Mulroney has contributed to 3 publications.

    Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells.

    Lamas, A. M., Mulroney, C. M., Schleimer, R. P.; J Immunol. 1988 Mar 1.

    See more >>

    The use of photodynamic therapy in bone marrow purging.

    Mulroney, C. M., Glück, S., Ho, A. D.; Semin Oncol. 1994 Dec.

    See more >>

    Nodal involvement by marginal zone B-cell lymphoma harboring t(14;22)(q32;q11) involving immunoglobulin heavy chain and light chain lambda as the sole karyotypically recognizable abnormality in a patient with systemic lupus erythematosus.

    Li, K.,Johnson, R. L.,Li, S.,Thorson, J. A.,Mulroney, C. M.,Dell'Aquila, M. L.,Wang, H. Y.; Int J Clin Exp Pathol. 2014 Sep 10.

    See more >>

    Memberships

    American Society of Clinical Oncology

    American Society of Hematology